GenBody is a leading manufacturer of in-vitro diagnostic medical devices, specializing in rapid antigen test kits for COVID-19 and clinical analysis instruments.
GenBody Inc. is a South Korean developer and manufacturer of in-vitro diagnostic medical devices. The company provides a range of rapid diagnostic tests (RDT), including the widely used GenBody COVID-19 Ag tests for professional point-of-care and at-home use. Their product line features high-quality rapid antigen tests, the Confiscope F40 analyzer, and other innovative healthcare solutions.
With manufacturing facilities in South Korea and the United States (GenBody America), they supply diagnostic test kits to healthcare providers and consumers under FDA Emergency Use Authorization (EUA). Their tests are designed for accurate qualitative detection of nucleocapsid protein antigens.
Titun Afowoyi lati manuals+ curated fun yi brand.
Awọn ibeere ti o wọpọ nipa awọn itọnisọna, iforukọsilẹ, ati atilẹyin fun ami iyasọtọ yii.
Two reddish-purple lines (C and T) indicate a positive result. One line at the C position indicates a negative result. If the C line does not appear, the test is invalid.
You can contact US Technical Support at 1-888-552-5204 or via email at ts@genbodyamerica.com.
Results should be read at 15 to 20 minutes. Do not read the results after 20 minutes as false positive or false negative results can occur.
GenBody COVID-19 Ag tests are authorized for use under the Food and Drug Administration's Emergency Use Authorization (EUA).